rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.14412/1995-4484-2012-719rsp-856Research ArticleСтатьиArticlesОтсроченная неблагоприятная реакция на фоне эффективного лечения тоцилизумабом рефрактерной болезни Стилла, развившейся у взрослыхDelayed poor response during effective tocilizumab treatment for refractory adult-onset Still's diseaseМуравьевЮ. В.MuravyevYuri Vladimirovichmurawyu@mail.ruAlekseyevaA VAlekseyevaA V-PodryadnovaM VPodryadnovaM V-201215062012503№3 (2012)117119Copyright © Муравьев Ю.В., Alekseyeva A.V., Podryadnova M.V., 20122012Муравьев Ю.В., Alekseyeva A.V., Podryadnova M.V.Muravyev Y.V., Alekseyeva A.V., Podryadnova M.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/856References<div><p>Bywaters E.G. Still’s disease in the adult. Ann Rheum Dis 1971;30:121-33.</p><p>Bannatyne G.A., Wohlmann A.S. Rheumatoid arthritis: its clinical history, etiology and pathology. Lancet 1896;1:1120-5.</p><p>Nakahara H., Mima T., Yoshio-Hoshino N. et al. A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years. Mod Rheumatol 2009;19:69-72.</p><p>Matsumoto K., Nagashima T., Takatori S. et al. Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab. Clin Rheumatol 2009;28:485-7.</p><p>De Bandt M., Saint-Marcoux B. Tocilizumab for multirefractory adult-onset Still's disease. Ann Rheum Dis 2009;68:153-4.</p><p>Perdan-Pirkmajer K., Praprotnik S., Tomsic M. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature. Clin Rheumatol 2010;29:1465-7.</p><p>Sumida K., Ubara Y., Hoshino J. et al. Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab. Clin Rheumatol 2010;29:1191-4.</p><p>Sabnis G.R., Gokhale Y.A., Kulkarni U.P. Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis - efficacy of interleukin-6 blockade and review of the literature. Semin Arthr Rheum 2011;40:365-8.</p><p>Puechal X., DeBandt M., Berthelot J.M. et al. Tocilizumab in refractory adult Still's disease. Arthr Care Res (Hoboken) 2011;63:155-9.</p><p>Yamaguchi M., Ohta A., Tsunematsu T. et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol 1992;19:424-30.</p><p>Naranjo C.A., Busto U., Sellers E.M. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.</p><p>Nakamura M., Tokura Y. Tocilizumab-induced erythroderma. Eur J Dermatol 2009;19:273-4.</p><p>Sugiura F., Kojima T., Oguchi T. et al. A case of peripheral neuropathy and skin ulcer in a patient with rheumatoid arthritis after a single infusion of tocilizumab. Mod Rheumatol 2009;19:199-203.</p></div><br /><div><p>Bywaters E.G. Still’s disease in the adult. Ann Rheum Dis 1971;30:121-33.</p><p>Bannatyne G.A., Wohlmann A.S. Rheumatoid arthritis: its clinical history, etiology and pathology. Lancet 1896;1:1120-5.</p><p>Nakahara H., Mima T., Yoshio-Hoshino N. et al. A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years. Mod Rheumatol 2009;19:69-72.</p><p>Matsumoto K., Nagashima T., Takatori S. et al. Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab. Clin Rheumatol 2009;28:485-7.</p><p>De Bandt M., Saint-Marcoux B. Tocilizumab for multirefractory adult-onset Still's disease. Ann Rheum Dis 2009;68:153-4.</p><p>Perdan-Pirkmajer K., Praprotnik S., Tomsic M. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature. Clin Rheumatol 2010;29:1465-7.</p><p>Sumida K., Ubara Y., Hoshino J. et al. Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab. Clin Rheumatol 2010;29:1191-4.</p><p>Sabnis G.R., Gokhale Y.A., Kulkarni U.P. Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis - efficacy of interleukin-6 blockade and review of the literature. Semin Arthr Rheum 2011;40:365-8.</p><p>Puechal X., DeBandt M., Berthelot J.M. et al. Tocilizumab in refractory adult Still's disease. Arthr Care Res (Hoboken) 2011;63:155-9.</p><p>Yamaguchi M., Ohta A., Tsunematsu T. et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol 1992;19:424-30.</p><p>Naranjo C.A., Busto U., Sellers E.M. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.</p><p>Nakamura M., Tokura Y. Tocilizumab-induced erythroderma. Eur J Dermatol 2009;19:273-4.</p><p>Sugiura F., Kojima T., Oguchi T. et al. A case of peripheral neuropathy and skin ulcer in a patient with rheumatoid arthritis after a single infusion of tocilizumab. Mod Rheumatol 2009;19:199-203.</p></div><br />
The authors declare that there are no conflicts of interest present.